Currently browsing: IP Practice in India

Delhi High Court sought Explanation through Counter Affidavit over Repudiation of Patent application for Xtandi

Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense grants. The drug was later […]

Read more

Fighting with Counterfeit Menace: Montblanc Simplo GmbH vs. Gaurav Bhatia & ors. CS(OS) 2563/2013: Granting Injunctive Relief

Introduction: It always has been a well-known fact that the markets in India are targeted by a large number of counterfeit products/goods. Popular brands like LV, GUCCI, […]

Read more